4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
China NT Pharma Group Company Limited (1011) operates in the Drug Manufacturers - Specialty & Generic industry and is headquartered in Central, Hong Kong with about 22 employees. Its market capitalization is roughly CNY 318 million. In the fiscal year ended 2025-12-31, 1011 reported CNY 24M in revenue and (CNY 26M) in net income.
China NT Pharma Group Company Limited, an investment holding company, engages in the investment, research and development, manufacture, sale, and distribution of pharmaceutical products in the People's Republic of China. It operates through Agency Services and Healthcare Related Services segments.
Interactive charts & full statements →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | CNY 24M | CNY 38M | CNY 7M | CNY 0M | — |
| Gross Profit | CNY 10M | CNY 5M | CNY 7M | CNY 125M | — |
| Operating Income (EBIT) | (CNY 12M) | (CNY 20M) | (CNY 56M) | (CNY 26M) | — |
| Net Income | (CNY 26M) | (CNY 53M) | (CNY 144M) | (CNY 66M) | — |
CNY; CNYM / CNYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | CNY 347M | CNY 334M | CNY 329M | CNY 1.0B | — |
| Total Liabilities | CNY 621M | CNY 733M | CNY 669M | CNY 1.2B | — |
CNY; CNYM / CNYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive 1011 viewer.
About TickerBase · Data methodology & sources · Privacy · Terms